Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Transmedics Group Inc shares valued at $164,729 were sold by Basile Edward M on Jun 05 ’24. At $138.08 per share, Basile Edward M sold 1,193 shares. The insider’s holdings dropped to 732 shares worth approximately $0.1 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Khayal Tamer I sold 2,960 shares, netting a total of over 393,986 in proceeds. Following the sale of shares at $133.10 each, the insider now holds 20,843 shares.
Before that, Gordon Stephen had sold 2,060 shares from its account. In a trade valued at $280,016, the Chief Financial Officer traded Transmedics Group Inc shares for $135.93 each. Upon closing the transaction, the insider’s holdings decreased to 2,060 shares, worth approximately $3.02 million.
As published in their initiating research note from Cantor Fitzgerald on June 06, 2024, Transmedics Group Inc [TMDX] has been an Overweight and the price target has been revised to $161. Analysts at Stephens started covering the stock with ‘”an Overweight”‘ outlook in a report released in early June. As of March 28, 2024, Piper Sandler has initiated its “an Overweight” rating for TMDX. Earlier on July 19, 2023, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for TMDX stock.
Analyzing TMDX Stock Performance
During the last five days, there has been a surge of approximately 5.03%. Over the course of the year, Transmedics Group Inc shares have jumped approximately 79.75%. Shares of the company reached a 52-week high of $146.12 on 06/11/24 and a 52-week low of $69.43 on 03/25/24. A 50-day SMA is recorded $116.47, while a 200-day SMA reached $81.17. Nevertheless, trading volume fell to 0.8 million shares from 0.69 million shares the previous day.
Support And Resistance Levels for Transmedics Group Inc (TMDX)
According to the 24-hour chart, there is a support level at 136.86, which, if violated, would cause prices to drop to 131.83. In the upper region, resistance lies at 145.34. The next price resistance is at 148.79. RSI (Relative Strength Index) is 63.54 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.66, which suggests the price will increase in the coming days. Percent R is at 24.26%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
